Physician profile
Brian E Walczak
NPI 1538366158
$9,933.70
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,359 · 2021: $114 · 2022: $199 · 2023: $496 · 2024: $5,767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,300 · Travel and Lodging: $1,907 · Food and Beverage: $1,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,300.00 |
| Travel and Lodging | $1,906.65 |
| Food and Beverage | $1,055.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $5,377.86 | 2019-2024 | Q-Fix, The Pink Hip Kit - Smith & Nephew Table, Cap-Fix |
| Linvatec Corporation | $3,621.82 | 2023-2024 | Biobrace 23mm, Livatec Knee Preservation System, Allograft Tissue |
| Stryker Corporation | $628.17 | 2019-2024 | Allomatrix, Gamma, Hipcheck |
| Linkbio Corp | $194.32 | 2023 | |
| Anika Therapeutics, INC. | $86.91 | 2024 | Integrity |
| Vericel Corporation | $24.62 | 2024 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Walczak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.